Influence of Chloroquine and Lidocaine on Retention and Cytotoxic Effects of [¹³¹I]EGF: Studies on Cultured Glioma Cells

References

• Amano F., Pastan I., Gottesman M.M. Genetic characterization of human KB cell lines resistant to epidermal growth factor: psuedomonas exotoxin conjugates. Journal of Cellular Physiology 1988; 135: 527–532
   PubMedGoogle Scholar
• Bigner S.H., Burger P.C., Wong A.J., Werner M.H., Hamilton S.R., Muhlbaier L.H., Vogelstein B., Bigner D.D. Gene amplification in malignant human gliomas: clinical and histopathologic aspects. Journal of Neuropathology and Experimental Neurology 1988; 47: 191–205
   PubMed Web of Science ®Google Scholar
• Burger P.C. Malignant astrocytic neoplasms: classification, pathologic anatomy and to treatment. Seminars in Oncology 1986; 13: 16–26
   PubMedGoogle Scholar
• Campbell I.D., Cooke R.M., Baron M., Harvey T.S., Tappin M.J. The solution structures of epidermal growth factor and transforming growth factor alpha. Progress in Growth Factor Research 1989; 1: 13–22
   PubMedGoogle Scholar
• Capala J., Pråhl M., Scott-Robson S., Pontén J., Westermark B., Carlsson J. Effects of 131-I-EGF on cultured human glioma cells. Journal of Neuro-Oncology 1990; 9: 201–210
   PubMed Web of Science ®Google Scholar
• Carlsson J., Daniel-Szolgay E., Frykholm G., Glimelius B., Hedin A., Larsson B. Homogeneous penetration but heterogeneous binding of anti-CEA antibodies in human colon carcinoma HT-29 spheroids. Cancer Immunology and Immunotherapy 1989; 30: 269–276
   PubMed Web of Science ®Google Scholar
• Carpenter G., Cohen S. 125-I labeled human growth factor. Journal of Cell Biology 1976; 71: 159–171
   PubMed Web of Science ®Google Scholar
• Di Marco E., Pierce J.H., Fleming T.P., Kraus M.H., Molloy C.J., Aaronson S.A., Di Fiore P.P. Autocrine interaction between TGFα and EGF receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 1989; 4: 831–838
   PubMed Web of Science ®Google Scholar
• Di Marco E., Pierce J.H., Aaronson S.A., Di Fiore P.P. Mechanisms by which EGF receptor and TGFα contribute to malignant transformation. Natural Immunity and Cell Growth Regulation 1990; 9: 209–221
   PubMedGoogle Scholar
• Forsberg J.O. Transient blood flow reduction induced by intra-arterial injection of degradable starch microspheres. Acta Chirurgica Scandinavica 1978; 144: 275–281
   PubMedGoogle Scholar
• Foster R.L. Preparation and properties of a soluble trypsin-dextran conjugate. Experentia 1975; 31: 773–774
   PubMedGoogle Scholar
• Goldenberg D.M. Targeting of cancer with radiolabelled antibodies. Prospects for imaging and therapy. Archives of Pathology and Laboratory Medicine 1988; 112: 580–587
   PubMed Web of Science ®Google Scholar
• Halperin E.C., Burger P.C., Bullard D.E. The fallacy of the localized supratentorial malignant glioma. International Journal of Radiation Oncology, Biology, Physics 1988; 15: 505–509
   PubMed Web of Science ®Google Scholar
• Heimbrook D.C., Stirdivant S.M., Ahern J.D., Balishin N.L., Patrick D.R., Edwards G.M., Defeo-Jones D., FitzGerald D.J., Pastan I., Oliff A. TGFα-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts. Proceedings of the National Academy of Sciences, USA 1990; 87: 4697–4701
   PubMed Web of Science ®Google Scholar
• Hendler F.J., Ozanne B.W. Human squamous cell lung cancers express increased epidermal growth factor receptors. Journal of Clinical Investigations 1984; 74: 647–651
   PubMed Web of Science ®Google Scholar
• Hill R.P. Metastasis. The Basic Science of Oncology, I.F. Tannock, R. Hill. Pergamon Press, New York 1987; 160–175, chapter 10
   Google Scholar
• Holmagren J. Tumour marker antigens. Properties and usefulness of carcinoma associated antigens. Chartwell-Bratt Ltd, Bromley 1985, CEA, CA 19-9 and CA-50
   Google Scholar
• Hsuan J.J., Panayotou G., Waterfield M.D. Structural basis for epidermal growth factor receptor function. Progress in Growth Factor Research 1989; 1: 23–32
   PubMedGoogle Scholar
• Humphrey P.A., Wong A.J., Vogelstein B., Friedman H.S., Werner M.H., Bigner D.D., Bigner S.H. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Research 1988; 48: 2231–2238
   PubMed Web of Science ®Google Scholar
• Kazunori H., Masharu T., Michio Y., Sadafumi O., Sawada J., Tanaka I. Isolation and characterization of E-64, a new thiol protease Inhibitor. Agricultural and Biological Chemistry Journal 1978; 42: 523–528
   Google Scholar
• Kwok C.S., Crivici A., MacGregor W.D., Unger M.W. Optimization of radioimmunotherapy using human malignant melanoma multicell spheroids as a model. Cancer Research 1989; 49: 3276–3281
   PubMed Web of Science ®Google Scholar
• Langmuir V.K., McGann J.K., Buchegger F., Sutherland R.M. 131I-anticarcinoembryonic antigen therapy of LS 174T human colon adenocarcinoma spheroids. Cancer Research 1989; 49: 3401–3406
   PubMed Web of Science ®Google Scholar
• Larsson B. Neutron capture therapy in support of other radiation treatment. Clinical Aspects of Neutron Capture Therapy, R.G. Fairchild, V.P. Bond, A.V. Woodhead. Plenum, New York 1989; 21–26
   Google Scholar
• Liberman T.A., Nusbaum H.R., Razon N., Kris R., Lax I., Soreq H., Whittle N., Waterfield M.D., Schlessinger J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 1985; 313: 144–147
   PubMedGoogle Scholar
• Lie S.L., Schofield B. Inactivation of lysosomal function in normal, cultured human fibroblast by chloroquine. Biochemical Pharmacology 1973; 22: 3109–3114
   PubMed Web of Science ®Google Scholar
• Lindberg B., Lote K., Teder H. Biodegradable starch microspheres—A new medical tool. Microspheres and Drug Therapy, S.S. Davis, L. Illum, J.G. McVie, E. Tomlinson. Elsevier, Amsterdam 1984; 153–188
   Google Scholar
• Lindmo T., Boven E., Mitchell J.B., Morstyn G., Bun P.A. Specific killing of human melanoma cells by 125-I labeled 9.2.27 monoclonal antibody. Cancer Research 1985; 45: 5080–5087
   PubMedGoogle Scholar
• Mateo De Acosta C., Justiz E., Skoog L., Lage A. Biodistribution of radioactive epidermal growth factor in normal and tumor bearing mice. Anticancer Research 1989; 9: 87–92
   PubMedGoogle Scholar
• Melton R.G., Wiblin C.N., Foster R.L., Sherwood R.F. Covalent linkage of carboxypeptidase G2 to soluble dextrans—I. Properties of conjugates and effects on plasma persistence in mice. Biochemical Pharmacology 1987; 36: 105–112
   PubMed Web of Science ®Google Scholar
• Mendelsohn J. Growth factor receptors as targets for antitumour therapy with monoclonal antibodies. Monoclonal Antibody Therapy 1988; 45: 147–160
   Google Scholar
• Nister M., Wedell B., Betsholtz C., Bywater M., Pettersson M., Westermark B., Mark J. Evidence for progressional changes in the human malignant glioma line U-343MGa: analysis of karyotype and expression of genes encoding the subunit chains of platelet-derived growth factor. Cancer Research 1987; 47: 4953–4960
   PubMed Web of Science ®Google Scholar
• Ozanne B.W., Richards C.S., Hendler F.J., Burns D., Gusterson B. Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. Journal of Pathology 1986; 149: 9–14
   PubMed Web of Science ®Google Scholar
• Pawlikowska T.R.B., Hooker G., Myers M., Epenetos A.A. Treatment of tumours with radiolabelled antibodies. Clinics in Oncology 1986; 5: 93–107
   Google Scholar
• Real F.X., Retting W.J., Chesa P.G., Melamed M.R., Old L.J., Mendelsohn J. Expression of EGF receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Research 1986; 46: 4726–4731
   PubMed Web of Science ®Google Scholar
• Reifenberger G., Prior R., Deckert M., Wechsler W. Epidermal growth factor receptor expression and growth fraction in human tumours of the nervous system. Virchows Archives (A) 1989; 414: 147–155
   Google Scholar
• Roberts P.J. Tumour markers in colorectal cancer. Scandinavian Journal of Gastroenterology 1988; 149: 50–58
   Google Scholar
• Schirrmacher V. Cancer metastasis: experimental approaches, theoretical concepts and impacts for treatment strategies. Advances in Cancer Research 1985; 43: 1–73
   PubMed Web of Science ®Google Scholar
• Scott-Robson S., Capala J., Carlsson J., Malmborg P., Lindqvist H. Distribution and stability in the rat of a 76Br/125I labelled polypeptide, epidermal growth factor. International Journal of Radiation Applications and Instrumentation. Part B: Nuclear Medicine and Biology 1991; 18: 241–246
   PubMedGoogle Scholar
• Shimizu N., Shimizu Y., Miskimins W.K. EGF-ricinA conjugates: kinetic profiles of cytotoxic effects and resistent cell variants. Cell Structure and Function 1984; 9: 203–212
   PubMedGoogle Scholar
• Starkhammar H. On the effect of degradable starch microspheres in intra-arterial chemotherapy. Linköping University medical thesis. 1987, No. 243
   Google Scholar
• Steck P.A., Gallick G.E., Maxwell S.A., Kloetzer W.S., Arlinghaus R.B., Moser R.P., Gutterman J.U., Yung W.K.A. Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells. Journal of Cellular Biochemistry 1986; 32: 1–10
   PubMedGoogle Scholar
• Todderud G., Carpenter G. Epidermal growth factor: the receptor and its function. BioFactors 1989; 2: 11–15
   PubMedGoogle Scholar
• Vaughan A.T.M., Anderson P., Dykes P.W., Chapman C.E., Bradwell A.R. Limitations to the killing of tumours using radiolabelled antibodies. British Journal of Radiology 1987; 60: 567–578
   PubMed Web of Science ®Google Scholar
• Vollmar A.M., Banker D.E., Mendelsohn J., Herschman H.R. Toxicity of ligand and antibody-directed ricin A-chain conjuates recognizing the epidermal growth factor receptor. Journal of Cellular Physiology 1987; 131: 418–425
   PubMed Web of Science ®Google Scholar
• Walker K.A., Murray T., Hildich T.E., Wheldon T.E., Gregor A., Hann I.M. A tumor spheroid model for antibody-targeted therapy of micrometastases. British Journal of Cancer 1988; 58: 13–16
   PubMedGoogle Scholar
• Weiss L. Principles of Metastasis. Academic Press, Orlando 1985
   Google Scholar
• Werner M.H., Humphrey P.A., Bigner D.D., Bigner S.H. Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines. Acta Neuropathologica 1988; 77: 196–201
   PubMed Web of Science ®Google Scholar
• Westermark B., Magnusson A., Heldin C.H. Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. Journal of Neuroscience Research 1982; 8: 491–507
   PubMed Web of Science ®Google Scholar
• Wheldon T.E., Donoghue J.A., Hilditch T.E., Barrett A. Strategies for systemic radiotherapy of micrometastases using anti-body targeted 131I. Radiotherapy and Oncology 1988; 11: 133–142
   PubMedGoogle Scholar